Literature DB >> 10925986

Histological evaluation of iron in liver biopsies: relationship to HFE mutations.

E M Brunt1, J K Olynyk, R S Britton, C G Janney, A M Di Bisceglie, B R Bacon.   

Abstract

OBJECTIVE: Hepatic iron overload is observed in many forms of chronic liver disease. Hereditary hemochromatosis (HH) results in hepatic iron overload and is associated with 2 missense mutations in the HFE gene. The aim of this study was to define the usefulness of the histological pattern of iron deposition in determining the probability of an iron-loaded patient having HFE-related iron overload.
METHODS: This study assessed liver biopsies containing stainable iron from 103 patients with various liver diseases; clinical information included hepatic iron concentration and HFE genotype (C282Y, H63D). The biopsies were evaluated using a reproducible histological scoring system for iron deposition. Three separate components of histological iron deposition were recorded: 1) pattern (primarily hepatocellular with a zonal gradient, or reticuloendothelial without an obvious zonal gradient), 2) pattern score to denote the extent of iron within the acinus, and 3) quantitation grade of iron granules within affected hepatocytes.
RESULTS: The predominantly hepatocellular pattern (HH pattern) was observed in 72 biopsies of which only 42 were from patients homozygous for the C282Y mutation, indicating that this pattern alone cannot be used as a surrogate marker for HH genotype. The predominantly reticuloendothelial pattern (non-HH pattern) was observed in the remaining 31 patients, none of whom was compound heterozygous or homozygous for the C282Y mutation (negative predictive value: 100%). Thus, the non-HH, reticuloendothelial pattern reliably predicts the absence of homozygosity for the C282Y mutation.
CONCLUSIONS: The use of histological evaluation for iron deposition is simple, assists in expanding information communicated from histopathologic observations, and may be clinically useful in determining the necessity of further evaluation of HFE genotype in subjects with histological evidence of hepatic iron overload.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925986     DOI: 10.1111/j.1572-0241.2000.02175.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

Review 2.  Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Ruben Hernaez; Edwina Yeung; Jeanne M Clark; Kris V Kowdley; Frederick L Brancati; Wen Hong Linda Kao
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

3.  Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis.

Authors:  R E Fleming; C C Holden; S Tomatsu; A Waheed; E M Brunt; R S Britton; B R Bacon; D C Roopenian; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

4.  Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C.

Authors:  Anneloes E Bohte; Annikki de Niet; Louis Jansen; Shandra Bipat; Aart J Nederveen; Joanne Verheij; Valeska Terpstra; Ralph Sinkus; Karin M J van Nieuwkerk; Rob J de Knegt; Bert C Baak; Peter L M Jansen; Henk W Reesink; Jaap Stoker
Journal:  Eur Radiol       Date:  2013-10-25       Impact factor: 5.315

5.  Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.

Authors:  Raymond Cheng; James C Barton; Elizabeth D Morrison; Pradyumna D Phatak; Edward L Krawitt; Stuart C Gordon; Kris V Kowdley
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

Review 6.  Screening for hemochromatosis: patients with liver disease, families, and populations.

Authors:  Sumedha P Galhenage; Charlie H Viiala; John K Olynyk
Journal:  Curr Gastroenterol Rep       Date:  2004-02

7.  Iron metabolism in mice with partial frataxin deficiency.

Authors:  Manuela M Santos; Carlos J Miranda; Joanne E Levy; Lynne K Montross; Mireille Cossée; Jorge Sequeiros; Nancy Andrews; Michel Koenig; Massimo Pandolfo
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

Review 8.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

9.  The influence of iron status and genetic polymorphisms in the HFE gene on the risk for postoperative complications after bariatric surgery: a prospective cohort study in 1,064 patients.

Authors:  Glenn S Gerhard; Ravi Chokshi; Christopher D Still; Peter Benotti; G Craig Wood; Mollie Freedman-Weiss; Cody Rider; Anthony T Petrick
Journal:  Patient Saf Surg       Date:  2011-01-10

Review 10.  Quantitative magnetic resonance imaging for chronic liver disease.

Authors:  Guilherme Moura Cunha; Patrick J Navin; Kathryn J Fowler; Sudhakar K Venkatesh; Richard L Ehman; Claude B Sirlin
Journal:  Br J Radiol       Date:  2021-02-26       Impact factor: 3.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.